Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 112 (RPL21P112)

Target
RPL21P112
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L21 pseudogene 112 (RPL21P112) is a non-functional, processed pseudogene related to the RPL21 gene, which encodes the ribosomal protein L21, a component of the 60S subunit of the ribosome[2][3]. Pseudogenes like RPL21P112 are remnants of gene duplication or retrotransposition events and do not encode functional protein products. Multiple processed pseudogenes related to ribosomal proteins exist in the genome, but they do not participate in ribosome structure or function and are not relevant as therapeutic targets[2][3][4]. RPL21P112 is not a therapeutic target but a non-functional pseudogene, and its inclusion as a druggable target or biomarker is considered incorrect in the context of drug discovery or molecular pharmacology. The functional homolog RPL21 (not the pseudogene) encodes a structural ribosomal protein, but this is a distinct entity[2][3][4].

Other names
RPL21_45_1329RPL21P112

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 112 (RPL21P112).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 112 (RPL21P112).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call